Immucell (ICCC) Current Leases (2020 - 2025)
Immucell's Current Leases history spans 6 years, with the latest figure at $85489.0 for Q4 2025.
- For Q4 2025, Current Leases fell 80.21% year-over-year to $85489.0; the TTM value through Dec 2025 reached $85489.0, down 80.21%, while the annual FY2025 figure was $85489.0, 80.21% down from the prior year.
- Current Leases reached $85489.0 in Q4 2025 per ICCC's latest filing, up from $82442.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $644276.0 in Q4 2023 to a low of $22920.0 in Q3 2022.
- Average Current Leases over 5 years is $220623.1, with a median of $107074.5 recorded in 2021.
- Peak YoY movement for Current Leases: surged 1928.32% in 2023, then plummeted 82.9% in 2025.
- A 5-year view of Current Leases shows it stood at $108012.0 in 2021, then tumbled by 70.59% to $31764.0 in 2022, then soared by 1928.32% to $644276.0 in 2023, then crashed by 32.94% to $432072.0 in 2024, then tumbled by 80.21% to $85489.0 in 2025.
- Per Business Quant, the three most recent readings for ICCC's Current Leases are $85489.0 (Q4 2025), $82442.0 (Q3 2025), and $322753.0 (Q2 2025).